The present invention concerns the process of preparing multicomponent lipid nanoparticles (LNPs) with high cellular futurogenicity for the delivery of nucleic acids and in particular for DNA vaccination. The invention also concerns the nanoparticles thus obtained. In particular, the lipid nanoparticles of the invention are obtained by combining cationic lipids and ionizable lipids in a specific ratio between them to be administered both subcutaneously (intradermal or intramuscular) and systemically with fewer side effects compared to the lipid nanoparticles known in the art.
La presente invenzione riguarda il processo di preparazione di nanoparticelle lipidiche multicomponenti (LNP) con elevata fusogenicità cellulare per la veicolazione di acidi nucleici e in particolare per la vaccinazione a DNA. L'invenzione riguarda anche le nanoparticelle così ottenute. In particolare, le nanoparticelle lipidiche dell'invenzione sono ottenute combinando lipidi cationici e lipidi ionizzabili in un rapporto specifico tra loro per essere somministrate sia per via sottocutanea (intradermica o intramuscolare) sia per via sistemica con minori effetti collaterali rispetto alle nanoparticelle lipidiche note nell'arte.
Nanoparticelle lipidiche multicomponenti ad alta fusogenicità cellulare per la vaccinazione a DNA e relativo processo di preparazione
CARACCIOLO Giulio;CARDARELLI Francesco
2022
Abstract
The present invention concerns the process of preparing multicomponent lipid nanoparticles (LNPs) with high cellular futurogenicity for the delivery of nucleic acids and in particular for DNA vaccination. The invention also concerns the nanoparticles thus obtained. In particular, the lipid nanoparticles of the invention are obtained by combining cationic lipids and ionizable lipids in a specific ratio between them to be administered both subcutaneously (intradermal or intramuscular) and systemically with fewer side effects compared to the lipid nanoparticles known in the art.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



